June 26, 2023

Precision for Medicine Acquires Baseline Controls, Expanding the Company’s End-to-End Manufacturing Solutions for Life Science Companies

Precision for Medicine, the first global biomarker-driven clinical research and development organization, today announced that it has acquired Baseline Controls, a Raleigh, North Carolina-based company that provides dedicated engineers with specialized expertise in project feasibility, execution planning, and baseline performance management.
Do you like it?
Read more
April 7, 2023

Precision for Medicine Expands Advanced Tissue Profiling and Genomic Capabilities with new Houston Laboratory

Houston is one of seven global Precision specialty labs addressing the rising demand for rapid, comprehensive biomarker data to support the development of advanced therapies and diagnostics HOUSTON, TX, April 12, 2023 – Precision for Medicine, the first global biomarker-driven clinical research organization, today announced the expansion of its cell […]
Do you like it?
Read more
123456789101112131415161718192021222324252627282930313233343536373839404142434445
Next page

Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

Visit the website